The CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to asthma: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 8, 2012, Pages 8525-8532

  Lee, Young Ho ^a   Choi, Sung Jae ^a   Ji, Jong Dae ^a   Song, Gwan Gyu ^a  

^a College of Medicine   (South Korea)

Author keywords

Asthma; Cytotoxic T lymphocyte antigen 4; Meta analysis; Polymorphism

Indexed keywords

ALANINE; CYSTEINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCINE; THREONINE;

AGE; ALLELE; ALLERGIC ASTHMA; ARTICLE; ASIAN; ASTHMA; CTLA4 GENE; ETHNICITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ADULT; CASE CONTROL STUDY; CAUCASIAN; CHILD; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PRESCHOOL CHILD; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE FACTORS; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CTLA-4 ANTIGEN; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; YOUNG ADULT;

EID: 84868659313     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1707-8     Document Type: Article

References (23)

1. Li X, Howard TD, Zheng SL, Haselkorn T, Peters SP, Meyers DA, Bleecker ER (2010) Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol 125(328-335):e311
2. Greenwald RJ, Oosterwegel MA, van der Woude D, Kubal A, Mandelbrot DA, Boussiotis VA, Sharpe AH (2002) CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol 32:366-373
3. Lee YH, Harley JB, Nath SK (2005) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 116:361-367
4. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC (2003) Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 423:506-511
5. Oh KY, Kang MJ, Choi WA, Kwon JW, Kim BJ, Yu J, Hong SJ (2010) Association between serum IgE levels and the CTLA-4 +49A/G and FCER1B -654C/T polymorphisms in Korean children with asthma. Allergy Asthma Immunol Res 2:127-133
6. Chan IH, Tang NL, Leung TF, Lam YY, Wong GW, Wong CK, Lam CW (2010) Association of plasma soluble CTLA-4 with lung function and gene polymorphism in Chinese asthmatic children. Int Arch Allergy Immunol 152:113-121
7. Sohn MH, Kim SH, Song TW, Kim KW, Kim ES, Park HS, Kim KE (2007) Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms confer susceptibility to atopic asthma in Korean children. Pediatr Pulmonol 42:542-547
8. Jasek M, Luszczek W, Obojski A, Winiarska B, Halubek K, Nowak I, Manczak M, Wisniewski A, Pawlik A, Jonkisz A, Lebioda A, Majorczyk E, Dobosz T, Kusnierczyk P (2006) Distribution of CTLA-4 polymorphisms in allergic asthma. Int Arch Allergy Immunol 141:223-229
9. Schubert K, von Bonnsdorf H, Burke M, Ahlert I, Braun S, Berner R, Deichmann KA, Heinzmann A (2006) A comprehensive candidate gene study on bronchial asthma and juvenile idiopathic arthritis. Dis Markers 22:127-132
10. Lee SY, Lee YH, Shin C, Shim JJ, Kang KH, Yoo SH, In KH (2002) Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 122:171-176
11. Hizawa N, Yamaguchi E, Jinushi E, Konno S, Kawakami Y, Nishimura M (2001) Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA-4 and FCER1B. J Allergy Clin Immunol 108:74-79
12. Nakao F, Ihara K, Ahmed S, Sasaki Y, Kusuhara K, Takabayashi A, Nishima S, Hara T (2000) Lack of association between CD28/CTLA-4 gene polymorphisms and atopic asthma in the Japanese population. Exp Clin Immunogenet 17:179-184
13. Lee YH, Harley JB, Nath SK (2006) Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 14:364-371
14. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2006) Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 27:157-161
15. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, Harley JB (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford) 46:49-56
16. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634
17. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
19. Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo VA Jr, Ke X, Gray GS, et al. (1995) CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92:811-815
20. Han S, Li Y, Mao Y, Xie Y (2005) Meta-analysis of the association of CTLA-4 exon-1 +49A/G polymorphism with rheumatoid arthritis. Hum Genet 118:123-132
21. Hellings PW, Vandenberghe P, Kasran A, Coorevits L, Overbergh L, Mathieu C, Ceuppens JL (2002) Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur J Immunol 32:585-594
22. van Oosterhout AJ, Deurloo DT, Groot PC (2004) Cytotoxic T lymphocyte antigen 4 polymorphisms and allergic asthma. Clin Exp Allergy 34:4-8
23. Munthe-Kaas MC, Carlsen KH, Helms PJ, Gerritsen J, Whyte M, Feijen M, Skinningsrud B, Main M, Kwong GN, Lie BA, Lodrup Carlsen KC, Undlien DE (2004) CTLA-4 polymorphisms in allergy and asthma and the TH1/TH2 paradigm. J Allergy Clin Immunol 114:280-287